v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
ASSETS    
Cash $ 1,447,919 $ 0
Prepaid expenses 122,995 31,827
Total current assets 1,570,914 31,827
Deferred offering costs 0 1,018,517
Cash held in Trust Account 221,233,834 0
Prepaid insurance - long term 89,909 0
Total Assets 222,894,657 1,050,344
Current liabilities    
Accounts payable 19,119 0
Promissory note - related party 300,000 300,000
Due to related party 813,107 509,158
Accrued expenses 1,168,335 512,925
Total current liabilities 2,300,561 1,322,083
Deferred underwriting fees payable 6,600,000 0
Advisory fees 6,600,000 0
Deferred legal fees 291,195 0
Total liabilities 15,791,756 1,322,083
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 22,000,000 shares at $10.06 per share 221,233,834 0
Shareholders' Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Additional paid-in capital 0 24,233
Accumulated deficit (14,131,686) (296,739)
Total shareholders' deficit (14,130,933) (271,739)
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit 222,894,657 1,050,344
Common Class A [Member]    
Shareholders' Deficit    
Common Stock 20 0
Common Class B [Member]    
Shareholders' Deficit    
Common Stock [1],[2] $ 733 $ 767
[1] In November 2025, the Company effected a share dividend with respect to the Company’s founder shares of 4,312,500 shares thereof, resulting in the Sponsor owning an aggregate of 11,500,000 founder shares. On April 22, 2026, our sponsor surrendered to us for no consideration an aggregate of 3,833,333 founder shares, which we accepted and canceled, resulting in our sponsor owning 7,666,667 founder shares for approximately $0.003 per share, due to the changes in the offering size. All share and per-share data have been retrospectively presented.
[2] This number includes an aggregate of 1,000,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full by the underwriter. On May 6, 2026, the underwriter partially exercised the over-allotment option and on May 8, 2026, purchased 2,000,000 units under the over-allotment option, reducing the shares subject to forfeiture to 333,333. The underwriter had until 45 days from the date of the Company’s Prospectus dated April 30, 2026 (the “Prospectus”) to exercise the remaining 1,000,000 units under the over-allotment option. (see Note 4). On June 15, 2026, upon the expiration of the over-allotment period, the underwriter forfeited their rights to exercise the remainder of the over-allotment option resulting in the sponsor forfeiting 333,333 Class B ordinary shares.